Kota V Ramana Selected Research

Cataract (Cataracts)

5/2011	Aldose reductase deficiency protects sugar-induced lens opacification in rats.
5/2004	Oxidative stress-induced up-regulation of the chloride channel and Na+/Ca2+ exchanger during cataractogenesis in diabetic rats.
7/2002	Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kota V Ramana Research Topics

Disease

28	Inflammation (Inflammations) 03/2021 - 02/2003
16	Diabetes Complications 01/2023 - 10/2002
16	Colonic Neoplasms (Colon Cancer) 01/2019 - 10/2006
15	Neoplasms (Cancer) 01/2021 - 10/2006
12	Uveitis 01/2022 - 10/2007
11	Hyperglycemia 01/2019 - 07/2002
7	Asthma (Bronchial Asthma) 01/2013 - 08/2009
5	Respiratory Hypersensitivity 01/2013 - 08/2009
5	Body Weight (Weight, Body) 06/2012 - 05/2004
4	Sepsis (Septicemia) 06/2010 - 10/2006
3	Colorectal Neoplasms (Colorectal Cancer) 12/2017 - 07/2007
3	Carcinogenesis 12/2014 - 04/2010
3	Cataract (Cataracts) 05/2011 - 07/2002
3	Macular Degeneration (Age-Related Maculopathy) 03/2011 - 01/2008
2	COVID-19 03/2023 - 01/2022
2	Hypoxia (Hypoxemia) 01/2019 - 07/2011
2	Cardiotoxicity 01/2018 - 01/2017
2	Cardiomyopathies (Cardiomyopathy) 01/2018 - 10/2006
2	Neoplasm Metastasis (Metastasis) 04/2013 - 08/2011
2	Metaplasia 01/2013 - 12/2010
2	Androgen-Insensitivity Syndrome (Testicular Feminization) 11/2011 - 10/2011
2	Aberrant Crypt Foci 05/2011 - 05/2009
2	Infections 06/2010 - 12/2009
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 12/2009 - 10/2006
1	Endotoxemia 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Hypertrophy 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Intestinal Polyps 01/2018
1	Intestinal Neoplasms (Intestinal Cancer) 01/2018
1	Polyps 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Obesity 12/2014

Drug/Important Bio-Agent (IBA)

44	Aldehyde Reductase (Aldose Reductase)IBA 03/2021 - 10/2002
19	EndotoxinsIBA 01/2019 - 10/2006
18	CytokinesIBA 01/2019 - 02/2003
13	polyolIBA 01/2023 - 10/2002
13	fidarestatIBA 03/2021 - 12/2010
12	EnzymesIBA 10/2013 - 03/2003
9	Glucose (Dextrose)FDA LinkGeneric 12/2014 - 07/2002
9	NF-kappa B (NF-kB)IBA 05/2010 - 08/2002
8	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 10/2006
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 02/2003
7	AldehydesIBA 01/2019 - 05/2005
7	Proteins (Proteins, Gene)FDA Link 04/2013 - 05/2004
6	LipopolysaccharidesIBA 01/2019 - 11/2006
6	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017 - 10/2009
6	LipidsIBA 01/2013 - 04/2007
5	AntioxidantsIBA 01/2019 - 05/2004
5	Transcription Factors (Transcription Factor)IBA 05/2011 - 08/2002
4	benphothiamine (benfotiamine)IBA 01/2022 - 05/2009
4	Thiamine (Aneurin)FDA Link 01/2022 - 05/2009
4	AllergensIBA 01/2013 - 08/2009
4	ChemokinesIBA 01/2013 - 11/2006
4	ragweed pollenIBA 11/2011 - 08/2009
3	Protein Kinase CIBA 01/2023 - 02/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2021 - 01/2017
3	AnthracyclinesIBA 03/2021 - 01/2017
3	3,3',4,5'-tetrahydroxystilbeneIBA 01/2017 - 10/2013
3	Epidermal Growth Factor (EGF)IBA 10/2013 - 04/2010
3	OvalbuminIBA 01/2013 - 10/2009
3	Glutathione (Reduced Glutathione)IBA 07/2011 - 10/2006
3	Dinoprostone (PGE2)FDA Link 07/2011 - 10/2006
2	Therapeutic UsesIBA 01/2021 - 06/2012
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019 - 07/2011
2	GlycosidesIBA 01/2019 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2011
2	FlavonoidsIBA 01/2019 - 01/2018
2	didyminIBA 01/2019 - 01/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 10/2010
2	Streptozocin (Streptozotocin)FDA Link 10/2017 - 04/2006
2	2-nonenalIBA 01/2014 - 04/2006
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 08/2011 - 10/2006
2	Small Interfering RNA (siRNA)IBA 07/2011 - 10/2006
2	Immunoglobulin E (IgE)IBA 05/2011 - 10/2009
2	MucinsIBA 05/2011 - 08/2009
2	AzoxymethaneIBA 05/2011 - 05/2009
2	Aldo-Keto ReductasesIBA 05/2011 - 04/2010
2	NADP (NADPH)IBA 05/2011 - 04/2010
2	Carotenoids (Carotene)IBA 03/2011 - 01/2008
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2007 - 10/2006
1	Antiviral Agents (Antivirals)IBA 03/2023
1	VitaminsIBA 03/2023
1	VaccinesIBA 03/2023
1	Advanced Glycation End ProductsIBA 01/2023
1	Sirtuin 1IBA 01/2019
1	3-nitrotyrosineIBA 01/2018
1	Synthetic DrugsIBA 01/2018
1	NLR ProteinsIBA 10/2017
1	InflammasomesIBA 10/2017
1	aspalatoneIBA 01/2017
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2017
1	CateninsIBA 12/2014
1	SurvivinIBA 12/2014
1	TNF-Related Apoptosis-Inducing LigandIBA 10/2013
1	MicroRNAs (MicroRNA)IBA 10/2013

Therapy/Procedure

6	Therapeutics 03/2023 - 07/2010
5	Drug Therapy (Chemotherapy) 03/2021 - 07/2011
2	Lenses 05/2011 - 07/2002
2	Subcutaneous Injections 10/2010 - 10/2007